- Home
- ESGR vs CORT Comparison
ESGR vs CORT Comparison
Compare ESGR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESGR
- CORT
- Stock Information
- Founded
- ESGR 2001
- CORT 1998
- Country
- ESGR Bermuda
- CORT United States
- Employees
- ESGR N/A
- CORT N/A
- Industry
- ESGR Property-Casualty Insurers
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ESGR Finance
- CORT Health Care
- Exchange
- ESGR Nasdaq
- CORT Nasdaq
- Market Cap
- ESGR 4.7B
- CORT 5.6B
- IPO Year
- ESGR N/A
- CORT N/A
- Fundamental
- Price
- ESGR $327.75
- CORT $68.11
- Analyst Decision
- ESGR
- CORT Strong Buy
- Analyst Count
- ESGR 0
- CORT 4
- Target Price
- ESGR N/A
- CORT $75.25
- AVG Volume (30 Days)
- ESGR 91.4K
- CORT 907.6K
- Earning Date
- ESGR 02-18-2025
- CORT 02-13-2025
- Dividend Yield
- ESGR N/A
- CORT N/A
- EPS Growth
- ESGR 51.73
- CORT 57.97
- EPS
- ESGR 66.06
- CORT 1.26
- Revenue
- ESGR $1,067,000,000.00
- CORT $628,555,000.00
- Revenue This Year
- ESGR N/A
- CORT $46.29
- Revenue Next Year
- ESGR N/A
- CORT $17.09
- P/E Ratio
- ESGR $4.95
- CORT $53.07
- Revenue Growth
- ESGR 17.90
- CORT 39.67
- 52 Week Low
- ESGR $265.00
- CORT $20.84
- 52 Week High
- ESGR $348.48
- CORT $71.29
- Technical
- Relative Strength Index (RSI)
- ESGR 60.01
- CORT 67.16
- Support Level
- ESGR $326.55
- CORT $64.66
- Resistance Level
- ESGR $327.75
- CORT $71.29
- Average True Range (ATR)
- ESGR 0.73
- CORT 3.32
- MACD
- ESGR -0.07
- CORT 1.12
- Stochastic Oscillator
- ESGR 39.81
- CORT 76.75
About ESGR Enstar Group Limited
Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through four reportable segments: Run-off, Assumed Life, Investments, and Legacy Underwriting.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.